The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial

Trials. 2020 May 25;21(1):430. doi: 10.1186/s13063-020-04407-x.

Eoin Feeney^{1

2}, Deborah Wallace³, Aoife Cotter^{2

4}, Willard Tinago², Cormac McCarthy^{1

2}, David Keane^{1

2}, Rabia Hussain², Elena Alvarez Barco², Peter Doran^{2

5}, Patrick Mallon^{1

2}

¹ St Vincent's University Hospital, Dublin, Ireland.
² School of Medicine, University College Dublin, Dublin, Ireland.
³ School of Medicine, University College Dublin, Dublin, Ireland. deborah.wallace@ucd.ie.
⁴ Mater Misericordiae University Hospital, Dublin, Ireland.
⁵ HRB-Trial Methodology Research Network, Galway, Ireland.

No abstract available

Publication types